Table 1 Demographic data and post-implantation outcomes

Pt. No.	Age (y)	Sex	Epilepsy duration (y)	Months implanted/ stimulated	Implanted depth along chosen trajectory	Epilepsy diagnosis	Seizure type	Seizure frequency
Pt. No.	Age (y)	Sex	Epilepsy duration (y)	Months implanted/ stimulated	Implanted depth along chosen trajectory	Epilepsy diagnosis	Seizure type	Before RNS	After RNS
RNS01	45	F	20	12/7	−1 mm −1 mm	JAE	Absence	~50/day	50–75% reduction
RNS01	45	F	20	12/7	−1 mm −1 mm	JAE	GTC	~1–2/week	None in last 7 mo
RNS02	26	F	11	11/5	−3.5 mm −3.5 mm	IGE	Absence	~1–10/day	50–75% reduction
							Myoclonus	~1−10/day	50–75% reduction
							GTC	~2–3/mo	None in last 2 mo
RNS03	21	F	8	10/8	−1 mm −1 mm	JAE	Absence	~40/day	50% reduction

CM centromedian nucleus of the thalamus, GTC general tonic-clonic seizure, JME juvenile myoclonic epilepsy, IGE idiopathic generalized epilepsy, JAE juvenile absence epilepsy, y year, mo months.

Quick links

Search